Skip to content

Promote Access to Stop Suicide: Comparison of Follow up Services for Youth at Risk for Suicide

PASS (Promote Access to Stop Suicide): A Randomized Controlled Trial Comparing Enhanced Treatment as Usual, Crisis Center Follow up and Wraparound Services for Youth at Risk for Suicide

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03016572
Acronym
PASS
Enrollment
65
Registered
2017-01-10
Start date
2017-05-04
Completion date
2021-08-31
Last updated
2021-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders, Depressive Disorder, Major, Suicidal Ideation, Suicidal Impulses, Suicide

Keywords

Suicide, Adolescent, Intervention, Crisis, Follow-Up

Brief summary

This research study is designed to answer specific questions about new ways to provide services for youth at-risk of suicide.

Detailed description

The proposed project will be able to provide services to high-risk youth in Ohio. This randomized controlled trial for youth discharged from inpatient psychiatric hospital will be able to determine what combination of services is best suited to reduce subsequent suicide attempts and re-hospitalization. All youth (ages 10-18), that fit the inclusion criteria, will be recruited from the inpatient unit at Fairview Youth Inpatient Unit. Patients will be consented, enrolled, and assigned to group by the Research Coordinator working at the unit. The Methodologist/ Statistician will generate a random allocation sequence using random number generator and communicate group assignment to the Research Coordinator. There will not be any restriction on randomization. The PI will be blinded to all group assignments. The clinical research tools and screens that will be administered in this study include: Columbia-Suicide Severity Rating Scale (C-SSRS), The Suicidal Ideation Questionnaire (SIQ), The Adverse Childhood Experiences (ACEs), Ohio Scales, Children's Global Assessment Scale (CGAS), Clinical Global Impressions (CGI-I). The participants of the study will be seen by the child psychiatrist (Dr. Varkula) and the research coordinator at the initial appointment, and a 6 month follow-up (Dr. Falcone). The C-SSRS and the SIQ will be administered at the initial appointment and the follow-up appointment. The study's research coordinator will be regulating the 3 month phone call and scheduling the 6 month up visit and administering the Ohio Scales questionnaire with the parents and/ or guardians of the child. There will also be a 12 month follow-up phone call conducted by the research coordinator. During this time, the information for the C-SSRS questionnaire, the SIQ, the Ohio Scales (for both the parent and the child), the CGI-I, and the CGAS will be administered.

Interventions

BEHAVIORALStandard of Care

Follow-Up Calls, Questionnaires

Frontline Services will be administering follow up phone calls for participants of the study, recently discharged from the emergency room.

BEHAVIORALWraparound Services

Tapestry will be assigning case management services for participants randomized into the third arm of the study.

Sponsors

Case Western Reserve University
CollaboratorOTHER
The Cleveland Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* All patients (ages 10-18 years) admitted to the Cleveland Clinic Inpatient Child and Adolescent psychiatry unit after a suicide ideation, behavior, or attempt. * This can be defined by any intentional, nonfatal self-injury, regardless of medical lethality, will be consider a suicide attempt if intent to die was indicated. * Signed consent by the adult patient (18 years) or by a first-degree relative or a guardian (for children) at the time of enrollment in the study, and assent by the children as soon as is feasible.

Exclusion criteria

* Patients with a known history of autistic spectrum disorder, non-verbal patients and moderate or severe mental retardation (IQ less than 70 and those patients in special education full time), patients with substance dependency and patients with schizophrenia. * Patients who are enrolled in case management will also be excluded from the study.

Design outcomes

Primary

MeasureTime frameDescription
Frequency of repeat suicide attempts in adolescents.up to 12 months post-dischargeFrequency of repeat suicide attempts during the 12 month follow up

Secondary

MeasureTime frameDescription
Frequency of readmissions after a suicide attempt in adolescents.up to 12 months post-dischargeFrequency of readmissions after a suicide attempt in adolescents
Relation between service type and frequency of repeat suicide attempts in adolescents.up to 12 months post-dischargeComparing the frequency of repeat suicide attempts in adolescents among the 3 service type treatment arms.
Relation between service type and frequency of readmissions after a suicide attempt in adolescents.up to 12 months post-dischargeComparing the frequency of readmissions after a suicide attempt in adolescents among the 3 service type treatment arms.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026